ASIC3 and neoplasm: Cancer-associated bone pain (CABP), affects >70% of metastatic bone cancer patients and the role osteoclasts and acidification have been implicated in the pain experienced with ASIC3 implicated being involved in transmission of CABP, such that ASIC3 expression is elevated in rat DRGs with tumor-associated CABP [155].